Nova Patents
EP4233545A3

Synergistic bacterial compositions and methods of production and use thereof

Abstract

Provided are therapeutic compositions containing ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.

Term

7.2 yearsto projected expiry

Projected expiry 25 November 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

Every citation, both ways

Citations
DocumentRelationOfficeCited during
WO0243649A2CitesWorld Intellectual Property Organization (WIPO)Search report
EP0446069A1CitesEuropean Patent Office (EPO)Search report
EP0456418A2CitesEuropean Patent Office (EPO)Search report
WO2005017095A2CitesWorld Intellectual Property Organization (WIPO)Search report
WO2007136553A2CitesWorld Intellectual Property Organization (WIPO)Search report
WO2012033814A2CitesWorld Intellectual Property Organization (WIPO)Search report
WO2012108830A1CitesWorld Intellectual Property Organization (WIPO)Search report
STUART JOHNSON ET AL: "Is primary prevention of Clostridium difficile infection possible with specific probiotics?", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 16, no. 11, 1 November 2012 (2012-11-01), CA, pages e786 - e792, XP055333236, ISSN: 1201-9712, DOI: 10.1016/j.ijid.2012.06.005Non-patent–Search report
MCFARLAND L V ET AL: "Pharmaceutical probiotics for the treatment of anaerobic and other infections", ANAEROBE, LONDON, GB, vol. 3, no. 2-3, 1 January 1997 (1997-01-01), pages 73 - 78, XP002137052, ISSN: 1075-9964, DOI: 10.1006/ANAE.1996.0062Non-patent–Search report
N. DENDUKURI: "Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review", CANADIAN MEDICAL ASSOCIATION JOURNAL, vol. 173, no. 2, 19 July 2005 (2005-07-19), pages 167 - 170, XP055026424, ISSN: 0820-3946, DOI: 10.1503/cmaj.050350Non-patent–Search report